WOODMONT INVESTMENT COUNSEL LLC - GW PHARMACEUTICALS PLC ownership

GW PHARMACEUTICALS PLC's ticker is GWPH and the CUSIP is 36197T103. A total of 116 filers reported holding GW PHARMACEUTICALS PLC in Q4 2015. The put-call ratio across all filers is 2.41 and the average weighting 0.3%.

Quarter-by-quarter ownership
WOODMONT INVESTMENT COUNSEL LLC ownership history of GW PHARMACEUTICALS PLC
ValueSharesWeighting
Q3 2017$203,000
+1.0%
2,0000.0%0.06%
-3.5%
Q2 2017$201,000
+1446.2%
2,000
+1900.0%
0.06%
+1325.0%
Q3 2016$13,000
-7.1%
100
-50.0%
0.00%0.0%
Q1 2016$14,0000.0%2000.0%0.00%0.0%
Q4 2015$14,000
-22.2%
2000.0%0.00%
-20.0%
Q3 2015$18,000
-25.0%
2000.0%0.01%
+25.0%
Q2 2015$24,0002000.00%
Other shareholders
GW PHARMACEUTICALS PLC shareholders Q4 2015
NameSharesValueWeighting ↓
GREAT POINT PARTNERS LLC 450,000$55,224,0004.41%
Parkman Healthcare Partners LLC 119,778$14,699,0004.14%
Sio Capital Management, LLC 94,984$11,656,0003.40%
Tamarack Advisers, LP 90,000$11,045,0003.08%
Copernicus Capital Management, LLC 22,000$2,700,0002.96%
Integral Health Asset Management, LLC 75,000$9,204,0002.76%
ETF MANAGERS GROUP, LLC 480,145$58,923,0002.09%
AdvisorShares Investments LLC 29,758$3,652,0001.55%
Redwood Investments, LLC 130,444$16,008,0001.42%
CLOUGH CAPITAL PARTNERS L P 100,746$12,364,0001.21%
View complete list of GW PHARMACEUTICALS PLC shareholders